How to use AT concentrate or recombinant thrombomodulin for the patients with sepsis analyzed by laboratory markers
Eguchi, Y.; Yoshida, T.; Okabe, H.
Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 213-215
2011
ISSN/ISBN: 0047-1860 PMID: 21761775 Document Number: 12937
Document emailed within 1 workday
Related Documents
Endo, S.; Inada, K.; Nakae, H.; Takakuwa, T.; Kasai, T.; Yamada, Y.; Suzuki, T.; Taniguchi, S.; Yoshida, M. 1995: Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis Research Communications in Molecular Pathology and Pharmacology 90(2): 277-288Baratto, F.; Michielan, F.; Gagliardi, G.; Di Gregorio, G.; Pasqualetto, A.; Meroni, M.; Giron, G.P. 2004: Use of protein C concentrate in adult patients with severe sepsis and septic shock Minerva Anestesiologica 70(5): 351-356
Pettenazzo, A.; Malusa, T. 2004: Use of protein C concentrate in critical conditions: clinical experience in pediatric patients with sepsis Minerva Anestesiologica 70(5): 357-363
Maruyama, I. 1999: Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation Thrombosis and Haemostasis 82(2): 718-721
Ohishi, R.; Watanabe, N.; Aritomi, M.; Gomi, K.; Kiyota, T.; Yamamoto, S.; Ishida, T.; Maruyama, I. 1993: Evidence that the protein C activation pathway amplifies the inhibition of thrombin generation by recombinant human thrombomodulin in plasma Thrombosis and Haemostasis 70(3): 423-426
Duman, A.; Turkdogan, K.A.; Avcil, M.; Yenisey, C.; Ture, M.; Akoz, A.; Dagli, B.; Kapci, M.; Orun, S. 2018: The predictive value of the inflammatory markers P-selectin and MCP1 in determining the length of stay and 30-day survival in the differentiation of sepsis patients JPMA. Journal of the Pakistan Medical Association 68(9): 1321-1326
Aguilera, A.; Selgas, R.; Ruiz-Caravaca, M.L.; Bajo, M.A.; Cuesta, M.V.; Plaza, M.A.; Hernanz, A. 1999: Effects of recombinant human erythropoietin on functional and injury endothelial markers in peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(Suppl 2): S161-S166
Solovyeva, L.N.; Shmonin, A.A.; Emanuel, Y.V.; Stolyarov, M.S.; Bondareva, E.A.; Mazing A V; Lazareva, N.M.; Kholopova, I.V.; Blinova, T.V.; Kharitonova, T.V.; Lapin, S.V.; Emanuel, V.L.; Melnikova, E.V. 2015: The Clinical Laboratory Markers of Atherosclerosis in Patients with Atherothrombotic Stroke Klinicheskaia Laboratornaia Diagnostika 60(10): 12-16
Sirchak, Y.S. 2016: Changes in Laboratory Markers of Endothelial Dysfunction in Patients with Liver Cirrhosis Eksperimental'naia i Klinicheskaia Gastroenterologiia 2016(7): 43-47
Kharlamova, U.V.; Il'icheva, O.E. 2012: The diagnostic value of laboratory markers of epithelium damage in patients passing the program hemodialysis Klinicheskaia Laboratornaia Diagnostika 2012(7): 39-41
Hisamuddin, N.A.R.Nik.; Azlan, K. 2012: The use of laboratory and physiological parameters in predicting mortality in sepsis induced hypotension and septic shock patients attending the emergency department Medical Journal of Malaysia 67(3): 259-264
Plak, Młgorzata.; Łobos, M.; Religa, W.; Tokarek, A.; Bonar, A.; Janas, B.; Paradowski, M. 2011: Evaluation of clinical usefulness of selected laboratory markers in the prediction of myocardial infarction in patients under secondary prevention Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 31(181): 9-14
Noor, M.K.; Shahidullah, M.; Mutanabbi, M.; Barua, C.; Mannan, M.A.; Afroza, S. 2008: Comparison between CRP and IL-6 as early markers of neonatal sepsis Mymensingh Medical Journal: Mmj 17(2 Suppl): S72-S76
Uszyiński, W.; Uszyński, M.ła.; Lisiecki, A. 2005: Novel treatment for severe sepsis: recombinant human protein C (RHAPC) Ginekologia Polska 76(11): 913-920
Lindahl, A.K.; Boffa, M.C.; Abildgaard, U. 1993: Increased plasma thrombomodulin in cancer patients Thrombosis and Haemostasis 69(2): 112-114
Kawczyński, P.ł; Piotrowski, A. 2004: Procalcitonin and C-reactive protein as a markers of neonatal sepsis Ginekologia Polska 75(6): 439-444
Zekanowska, E.; Cieśliński, K.; Kotschy, M.; Lambrecht, W. 2001: Levels of soluble thrombomodulin in blood of patients with lung cancer Pneumonologia i Alergologia Polska 69(3-4): 174-178
Soriano, V.; Tor, J.; Muga, R.; Clotet, B.; Ribera, A.; Foz, M. 1988: Serological markers of human immunodeficiency virus infection in African patients with AIDS: are they different from markers found in patients from other countries? Journal of Infectious Diseases 158(4): 894
Liang, J.; Streat, S.; Torrance, J.; Sleigh, J.; Freebairn, R.; Ramsay, M. 2003: Drotrecogin alfa (recombinant human activated protein C) in severe sepsis--a New Zealand viewpoint New Zealand Medical Journal 116(1181): U586
Walker, I.; Poon, M.C. 1992: Recombinant factor VIII concentrate. The MSAC, Canadian Hemophilia Society. Canadian Hemophilia Clinic Directors Group Lancet 339(8784): 61-62